Cancer survivors without health insurance have greater current smoking rates
the ONA take:
Cancer survivors without health insurance have substantially greater current smoking rates than those with health insurance, a recent study published in the Journal of Cancer Survivorship: Research and Practice has shown.
For the cross-sectional study, researchers sought to examine the prevalence of current smoking, and to evaluate the association of both health insurance and access to care with smoking cessation among cancer survivors.
Researchers analyzed data from 18,896 cancer survivors who completed the 2009 Behavioral Risk Factor Surveillance System survey. Respondents were mostly 45 to 64 years of age, white, and female.
Results showed that the prevalence of current smoking was 40.9% among cancer survivors without health insurance compared with 19.5% of those with health insurance.
Researchers also found that cancer survivors with no health insurance had a 2-fold greater odds of not achieving smoking cessation versus those with health insurance.
Those who experienced health care access-related problems despite having health insurance had a 60-80% gold greater odds of not achieving smoking cessation compared with cancer survivors without access problems.
The findings suggest that "smoking cessation needs to be recognized as a crucial component of preventive care for cancer survivors."
Cancer survivors without health insurance have substantially greater current smoking rates than those with health insurance.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|